# Oxford Square Capital Corp.: overview OXSQ · Nasdaq · CIK 1259429 · [Other](/sectors/other.md) · fiscal year ends Dec 31 Pages: [Overview](/companies/oxsq.md) · [Financials](/companies/oxsq/financials.md) · [Filings](/companies/oxsq/filings.md) · [Insiders](/companies/oxsq/insiders.md) Revenue is not reported in this company’s XBRL financial statements. ## Last eight quarters | Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | | --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.10](/filings/0001213900-25-107316.md) | not reported | [0.09](/filings/0001213900-26-050934.md) | [0.08](/filings/0001213900-26-087243.md) | [0.07](/filings/0001213900-25-107316.md) | not reported | [0.05](/filings/0001213900-26-050934.md) | [0.05](/filings/0001213900-26-087243.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. Derived values: 12-month figure less the 9-month figure. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure. ## Last five fiscal years | Line item | Unit | FY (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) | | --- | --- | ---: | ---: | ---: | ---: | ---: | | Revenue | $ | not reported | not reported | not reported | not reported | not reported | | Gross margin | % | not reported | not reported | not reported | not reported | not reported | | Operating margin | % | not reported | not reported | not reported | not reported | not reported | | Net margin | % | not reported | not reported | not reported | not reported | not reported | | Diluted EPS | $ per share | [0.32](/filings/0001213900-24-023660.md) | [0.42](/filings/0001213900-25-020801.md) | [0.51](/filings/0001213900-26-024280.md) | [0.42](/filings/0001213900-26-024280.md) | [0.30](/filings/0001213900-26-024280.md) | | Free cash flow | $ | not reported | not reported | not reported | not reported | not reported | - Revenue. XBRL not reported. - Gross margin (gross profit / revenue). XBRL not reported. - Operating margin (operating income / revenue). XBRL not reported. - Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss. - Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted. - Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities. Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing. ## Insider purchases and sales The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/oxsq/insiders.md) None in coverage. ## Funds that report holding it From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md) | Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before | | --- | --- | ---: | ---: | --- | --- | | [Legal & General Group Plc](/funds/764068.md) | 2026-06-30 | $960.9k | 725,171 | | Added +137,823 | | [UBS Group AG](/funds/1610520.md) | 2026-06-30 | $399.3k | 302,528 | | Added +189,767 | | [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $382.9k | 290,041 | | Reduced −7,391 | | [Virtus Investment Advisers, LLC](/funds/19481.md) | 2026-06-30 | $315.9k | 239,321 | | Added +25,833 | | [BRIAN LOW FINANCIAL GROUP, LLC](/funds/2079080.md) | 2026-06-30 | $166.3k | 126,000 | | New +126,000 | | [Strategic Wealth Partners, Ltd.](/funds/1720777.md) | 2026-06-30 | $166.3k | 126,000 | | New +126,000 | | [Silverberg Bernstein Capital Management LLC](/funds/2007880.md) | 2026-06-30 | $140.9k | 106,710 | | Unchanged | | [MORGAN STANLEY](/funds/895421.md) | 2026-06-30 | $120.6k | 91,343 | | Added +26,563 | | [McIlrath & Eck, LLC](/funds/1701714.md) | 2026-03-31 | $115.7k | 65,375 | | Not compared | | [Founders Financial Alliance, LLC](/funds/1832190.md) | 2026-06-30 | $112.0k | 84,865 | | Unchanged | ## Recent filings [All 759 filings](/companies/oxsq/filings.md) | Filed | Accepted | Form | What it is | Accession | | --- | --- | --- | --- | --- | | 2026-09-14 | 16:06 ET | [8-K](/filings/0001213900-26-099703.md) | 8.01 Other events | 0001213900-26-099703 | | 2026-08-20 | 17:27 ET | [8-K](/filings/0001213900-26-092208.md) | 5.07 Shareholder vote results | 0001213900-26-092208 | | 2026-08-10 | 16:12 ET | [10-Q](/filings/0001213900-26-087243.md) | Quarterly report, period 2026-06-30 | 0001213900-26-087243 | | 2026-07-31 | 17:06 ET | [8-K](/filings/0001213900-26-084087.md) | 8.01 Other events; 9.01 Financial statements and exhibits | 0001213900-26-084087 | | 2026-07-31 | 08:00 ET | [8-K](/filings/0001213900-26-083625.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001213900-26-083625 | | 2026-07-08 | 16:39 ET | [DEF 14A](/filings/0001213900-26-076403.md) | Proxy statement, period 2026-08-20 | 0001213900-26-076403 | | 2026-05-29 | 16:31 ET | [8-K](/filings/0001213900-26-062870.md) | 4.01 Change of auditor; 9.01 Financial statements and exhibits | 0001213900-26-062870 | | 2026-05-11 | 17:42 ET | [8-K](/filings/0001213900-26-054051.md) | 5.03 Amendment to articles or bylaws; 9.01 Financial statements and exhibits | 0001213900-26-054051 | | 2026-05-06 | 21:44 ET | [8-K](/filings/0001213900-26-052505.md) | 1.01 Entry into a material agreement; 9.01 Financial statements and exhibits | 0001213900-26-052505 | | 2026-05-01 | 16:05 ET | [10-Q](/filings/0001213900-26-050934.md) | Quarterly report, period 2026-03-31 | 0001213900-26-050934 | ## Latest annual report [Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001213900-26-024280.md), filed Mar 6, 2026. ## Forecast league Not in this season’s league. [This season’s league](/leagues.md) ## About the filer - CIK: 1259429 - Tickers: OXSQ, OXSQG, OXSQH - Exchange: Nasdaq - SIC code: not reported - State of incorporation: MD - Filer category: Non-accelerated filer Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 30, 2026, 08:31 ET. No prices; not investment advice.